作者
Mahmoud Tawfik KhalafAllah, Ahmed Basiony, Ahmed Salama
发表日期
2019/11/1
来源
BMJ open
卷号
9
期号
11
页码范围
e026752
出版商
British Medical Journal Publishing Group
简介
Objective
Topical steroids are the cornerstone in controlling the inflammation after cataract surgery. Prednisolone acetate and difluprednate are the two main products for this purpose. However, it is unclear which one should be used in terms of effectiveness and safety.
Design
Systematic review and meta-analysis.
Data sources
Medline via PubMed, Cochrane Central Register of Controlled Trials, Web of science and clinicaltrials.gov were searched through 10 January 2018, and updated on 20 July 2019, in addition to researching the references’ lists of the relevant articles.
Eligibility criteria
Randomised-controlled trials (RCTs) comparing difluprednate and prednisolone acetate regardless of the dosing regimen used.
Data extraction and synthesis
Two independent authors assessed the included RCTs regarding the risk of bias using the Cochrane tool. Relevant data were extracted, and meta-analysis was conducted …
学术搜索中的文章
MT KhalafAllah, A Basiony, A Salama - BMJ open, 2019